• Home
  • >
  • Astec Lifesciences Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/astec-lifesciences-ltd.png Logo

Astec Lifesciences Ltd Financial Statement

Astec Lifesciences Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue155.7851.69111.74
Operating Expense141.0469.12114.21
Net Profit-0.99-24.35-13.45
Net Profit Margin-0.64-47.11-12.04
Earning Per Share-0.5-12.42-6.86
EBIDTA14.71-9.531.72
Effective Tax RateTBATBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Astec Lifesciences Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual628.17676.57554.87
Operating Expenses Annual551.91522.49443.32
Operating Profit Annual89.31164.54119.48
Interest Annual20.719.064.75
Depreciation32.4833.2924.85
Net Profit Annual25.5689.8665.05
Tax Annual9.3531.2424

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Astec Lifesciences Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning0.550.340.31
Cash Flow from Operations74.6623.6-8.16
Cash Flow from Investing-112.51-103.87-73.14
Cash Flow from Financing37.7780.4881.34
Cash Flow at the End0.470.550.34

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Astec Lifesciences Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)14.2224.3221.53
PBIT Margin (%)8.8619.2416.91
PBT Margin (%)8.4317.1213.35
Net PROFIT Margin (%)4.0613.2811.66
Return On Networth / Equity (%)6.2725.4723.42
Return On Networth /Employed(%)7.7322.1722.27
Return On Assets (%)3.5315.2715.39
Total Debt / Equity(X)0.760.660.52
Asset Turnover Ratio (%)0.871.151.32

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Astec Lifesciences Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual332.69349.04216.71
Total Current Assets Annual498.85515.68330.43
Non Current Assets Annual480.56381.08347.16
Total Shareholders Funds Annual419.36396.5309.18
Total Assets Annual979.41896.76677.59

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Astec Lifesciences Ltd Earning Calls
Mar 2024
EPS beaten by 2.04 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Astec Lifesciences Ltd has a market capitalization of 2,082.6 Cr. Value Research classifies it as a Mid-Cap company.

No, Astec Lifesciences Ltd is not debt-free with a debt-to-equity ratio of 1.34.

In FY 2023, Astec Lifesciences Ltd recorded a total revenue of approximately 458.18 Cr marking a significant milestone in the company's financial performance.

Astec Lifesciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and -0.2% annually, respectively..

Astec Lifesciences Ltd's current PE ratio is -44.38.

Astec Lifesciences Ltd's ROCE averaged 7.4% from the FY ending March 2022 to 2024, with a median of 7.3%. It peaked at 19.2% in March 2022, reflecting strong capital efficiency over the period..

Astec Lifesciences Ltd's latest EBIT is Rs. -36.52 Cr, surpassing the average EBIT of Rs. 49.78 Cr over the 5 years..